is being presented by Helen Colquhoun, CEO, of Pleiad Inc. and airs on Wednesday, November 2nd, 2011. For more details or to register, please visit our site at www.fxconferences.com
There are many challenges facing those who design, set up, and monitor ophthalmology trials. The first is deciding whether to study one eye or both eyes, and to understand the statistical implications of that choice. The next challenge is to understand the many assessments, measurements, and endpoints utilized in ophthalmology trials, and how to standardize their collection over many sites. Finally, monitors need to understand the data they are monitoring, in order to identify adverse trends and improbable values, thereby improving data quality.
In this audio conference, our speaker reviews the common and some not-so-common ophthalmic tests used as outcome measures in clinical trials, giving pointers for monitoring best practices in ophthalmology, and discussing site certification and standardization. The presentation also describes the statistical and study design issues, so that attendees understand how they will impact their decisions about study design and analysis.
